Wellington Management Group’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $263M | Sell |
9,249,690
-434,866
| -4% | -$12.4M | 0.05% | 301 |
|
|
2025
Q1 | $286M | Buy |
9,684,556
+1,578,459
| +19% | +$46.6M | 0.06% | 267 |
|
|
2024
Q4 | $236M | Buy |
8,106,097
+1,075,148
| +15% | +$31.3M | 0.04% | 333 |
|
|
2024
Q3 | $323M | Buy |
7,030,949
+3,228,923
| +85% | +$148M | 0.06% | 285 |
|
|
2024
Q2 | $155M | Buy |
3,802,026
+2,573,028
| +209% | +$105M | 0.03% | 440 |
|
|
2024
Q1 | $31.4M | Buy |
1,228,998
+937,780
| +322% | +$23.9M | 0.01% | 838 |
|
|
2023
Q4 | $2.64M | Buy |
291,218
+43,147
| +17% | +$390K | ﹤0.01% | 1436 |
|
|
2023
Q3 | $1.58M | Buy |
248,071
+12,835
| +5% | +$81.9K | ﹤0.01% | 1518 |
|
|
2023
Q2 | $2.61M | Buy |
235,236
+91,366
| +64% | +$1.01M | ﹤0.01% | 1430 |
|
|
2023
Q1 | $2.21M | Buy |
143,870
+5,461
| +4% | +$83.8K | ﹤0.01% | 1491 |
|
|
2022
Q4 | $3.07M | Sell |
138,409
-59,884
| -30% | -$1.33M | ﹤0.01% | 1394 |
|
|
2022
Q3 | $3.24M | Sell |
198,293
-869,930
| -81% | -$14.2M | ﹤0.01% | 1400 |
|
|
2022
Q2 | $15.5M | Sell |
1,068,223
-67,521
| -6% | -$981K | ﹤0.01% | 1011 |
|
|
2022
Q1 | $21M | Buy |
1,135,744
+112,024
| +11% | +$2.07M | ﹤0.01% | 1003 |
|
|
2021
Q4 | $24.3M | Buy |
1,023,720
+414,457
| +68% | +$9.85M | ﹤0.01% | 1029 |
|
|
2021
Q3 | $15M | Buy |
609,263
+141,807
| +30% | +$3.49M | ﹤0.01% | 1157 |
|
|
2021
Q2 | $11.6M | Buy |
467,456
+151,445
| +48% | +$3.74M | ﹤0.01% | 1228 |
|
|
2021
Q1 | $6.89M | Sell |
316,011
-225,404
| -42% | -$4.92M | ﹤0.01% | 1348 |
|
|
2020
Q4 | $13.8M | Sell |
541,415
-206,692
| -28% | -$5.27M | ﹤0.01% | 1104 |
|
|
2020
Q3 | $21.1M | Sell |
748,107
-126,981
| -15% | -$3.57M | ﹤0.01% | 944 |
|
|
2020
Q2 | $24.7M | Buy |
+875,088
| New | +$24.7M | 0.01% | 880 |
|